GSK stock jumped Wednesday after the British drugmaker said it's "well positioned" to respond if the Trump administration ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

GSK’s dealmaking will be “cautious and disciplined” under the current trade war, but the pharma will focus on looking for ...

GSK PLC GSK shares advanced 3.60% to £14.84 Wednesday, on what proved to be an all-around favorable trading session for the ...

GSK is 'well positioned' to deal with the potential implications of any new US tariffs on pharma imports, the group said on ...

GSK said its decoupling with Haleon is a key reason why it views itself as “well-positioned” in the face of potential ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Data from the NERO study was presented at the American Association of Cancer Research (AACR) Annual Meeting 2025.

The British pharmaceutical giant said that its first-quarter sales rose to 7.52 billion pounds from 7.36 billion pounds the ...

GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...

In its update, GSK reported a 17% rise in speciality medicines across its HIV, cancer and respiratory business to £2.93 ...